203 related articles for article (PubMed ID: 30171816)
21. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.
Jin Z; Gu C; Tian F; Jia Z; Yang J
Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304
[TBL] [Abstract][Full Text] [Related]
22. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.
Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY
Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway.
Huang Z; Li S; Fan W; Ma Q
Oncotarget; 2017 May; 8(20):33560-33570. PubMed ID: 28432277
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor β attenuates renal fibrosis by suppressing the transcriptional activity of Smad3.
Cao R; Su W; Sheng J; Guo Y; Su J; Zhang C; Wang H; Tang Y; Chen L; Qiao R; Chen X; Huang X; Zhou Y; Zhu L; Bai Z; Zhang X; Gustafsson JA; Wan Q; Lan HY; Guan Y
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166755. PubMed ID: 37196860
[TBL] [Abstract][Full Text] [Related]
26. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway.
He D; Li L; Zhu G; Liang L; Guan Z; Chang L; Chen Y; Yeh S; Chang C
Cancer Res; 2014 Aug; 74(16):4420-30. PubMed ID: 24924778
[TBL] [Abstract][Full Text] [Related]
27. Hormone signaling pathways as treatment targets in renal cell cancer (Review).
Czarnecka AM; Niedzwiedzka M; Porta C; Szczylik C
Int J Oncol; 2016 Jun; 48(6):2221-35. PubMed ID: 27035677
[TBL] [Abstract][Full Text] [Related]
28. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
29. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
32. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract][Full Text] [Related]
33. Association of β-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-β1.
Tian X; Zhang J; Tan TK; Lyons JG; Zhao H; Niu B; Lee SR; Tsatralis T; Zhao Y; Wang Y; Cao Q; Wang C; Wang Y; Lee VW; Kahn M; Zheng G; Harris DC
J Cell Sci; 2013 Jan; 126(Pt 1):67-76. PubMed ID: 23203799
[TBL] [Abstract][Full Text] [Related]
34. Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer.
Fan S; Liao Y; Qiu W; Li L; Li D; Cao X; Ai B
Clin Transl Oncol; 2020 Nov; 22(11):2074-2086. PubMed ID: 32367494
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
36. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
[TBL] [Abstract][Full Text] [Related]
37. The oncogenic role of MUC12 in RCC progression depends on c-Jun/TGF-β signalling.
Gao SL; Yin R; Zhang LF; Wang SM; Chen JS; Wu XY; Yue C; Zuo L; Tang M
J Cell Mol Med; 2020 Aug; 24(15):8789-8802. PubMed ID: 32596961
[TBL] [Abstract][Full Text] [Related]
38. The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma.
Zhou Y; Tong L; Chu X; Deng F; Tang J; Tang Y; Dai Y
Cell Physiol Biochem; 2017; 43(2):733-742. PubMed ID: 28950257
[TBL] [Abstract][Full Text] [Related]
39. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.
Jeon WK; Choi J; Park SJ; Jo EJ; Lee YK; Lim S; Kim JH; Letterio JJ; Liu F; Kim SJ; Kim BC
Oncotarget; 2015 Dec; 6(39):41650-66. PubMed ID: 26497676
[TBL] [Abstract][Full Text] [Related]
40. Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα
Shea MP; O'Leary KA; Fakhraldeen SA; Goffin V; Friedl A; Wisinski KB; Alexander CM; Schuler LA
Cancer Res; 2018 Apr; 78(7):1672-1684. PubMed ID: 29363543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]